AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35
Apolipoprotein A-I(R151C)(Paris) is defective in activation of lecithin : cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux
Authors: Daum, U Langer, C Duverger, N Emmanuel, F Benoit, P Denefle, P Chirazi, A Cullen, P Pritchard, PH Bruckert, E Assmann, G von Eckardstein, A
Citation: U. Daum et al., Apolipoprotein A-I(R151C)(Paris) is defective in activation of lecithin : cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux, J MOL MED-J, 77(8), 1999, pp. 614-622
Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis
Authors: Cullen, P Soffker, J Hopfl, M Bremer, C Schlaghecken, R Mehrens, T Assmann, G Schaefer, RM
Citation: P. Cullen et al., Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis, NEPH DIAL T, 14(3), 1999, pp. 659-665
Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque
Authors: Weitkamp, B Cullen, P Plenz, G Robenek, H Rauterberg, J
Citation: B. Weitkamp et al., Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque, FASEB J, 13(11), 1999, pp. 1445-1457
Coronary heart disease prevention task force
Authors: Assmann, G Cullen, P Fruchart, C Lewis, B Mancini, M Carmena, R
Citation: G. Assmann et al., Coronary heart disease prevention task force, EUR HEART J, 20(11), 1999, pp. 841-843
Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome
Authors: Matzkies, FK Cullen, P Schaefer, L Hartmann, M Hohage, H Schaefer, RM
Citation: Fk. Matzkies et al., Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome, SOUTH MED J, 92(12), 1999, pp. 1157-1161
Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I (R160L)(Oslo) and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers
Authors: Daum, U Leren, TP Langer, C Chirazi, A Cullen, P Pritchard, PH Assmann, G von Eckardstein, A
Citation: U. Daum et al., Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I (R160L)(Oslo) and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers, J LIPID RES, 40(3), 1999, pp. 486-494
Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM)
Authors: Schulte, H Cullen, P Assmann, G
Citation: H. Schulte et al., Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM), ATHEROSCLER, 144(1), 1999, pp. 199-209
High risk strategies for atherosclerosis
Authors: Cullen, P Assmann, G
Citation: P. Cullen et G. Assmann, High risk strategies for atherosclerosis, CLIN CHIM A, 286(1-2), 1999, pp. 31-45
Coronary heart disease: Reducing the risk - A worldwide view
Authors: Assmann, G Carmena, R Cullen, P Fruchart, JC Jossa, F Lewis, B Mancini, M Paoletti, R
Citation: G. Assmann et al., Coronary heart disease: Reducing the risk - A worldwide view, CIRCULATION, 100(18), 1999, pp. 1930-1938
Pravastatin and coronary heart disease
Authors: Assmann, G Schulte, H Cullen, P
Citation: G. Assmann et al., Pravastatin and coronary heart disease, CIRCULATION, 98(25), 1998, pp. 2933-2934
Risultati: 1-25 | 26-35 |